CLINICAL TRIALS PROFILE FOR CLIMARA PRO
✉ Email this page to a colleague
505(b)(2) Clinical Trials for Climara Pro
| Trial Type | Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|---|
| New Formulation | NCT00649896 ↗ | Evaluation of Adhesion Quality of a New Formulation of the Mylan Estradiol Transdermal System 0.025 mg/Day and Climara® Transdermal System 0.025 mg/Day | Completed | Mylan Pharmaceuticals | Phase 1 | 2003-08-01 | The primary objective of this study was to compare the adhesive quality of a new formulation of the Mylan Estradiol Transdermal System with that of Climara® Transdermal System following a single system application in 80 healthy postmenopausal female volunteers. As a secondary objective, primary dermal irritation was assessed after removal of each transdermal system. |
| >Trial Type | >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
All Clinical Trials for Climara Pro
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00154180 ↗ | Kronos Early Estrogen Prevention Study (KEEPS) | Unknown status | Albert Einstein College of Medicine | Phase 4 | 2005-09-01 | The study will examine the effects of estrogen and progesterone on the development of atherosclerosis in menopausal women when hormone treatment is initiated within 3 years of the menopausal transition. |
| NCT00154180 ↗ | Kronos Early Estrogen Prevention Study (KEEPS) | Unknown status | Albert Einstein College of Medicine of Yeshiva University | Phase 4 | 2005-09-01 | The study will examine the effects of estrogen and progesterone on the development of atherosclerosis in menopausal women when hormone treatment is initiated within 3 years of the menopausal transition. |
| NCT00154180 ↗ | Kronos Early Estrogen Prevention Study (KEEPS) | Unknown status | Brigham and Women's Hospital | Phase 4 | 2005-09-01 | The study will examine the effects of estrogen and progesterone on the development of atherosclerosis in menopausal women when hormone treatment is initiated within 3 years of the menopausal transition. |
| NCT00154180 ↗ | Kronos Early Estrogen Prevention Study (KEEPS) | Unknown status | Columbia University | Phase 4 | 2005-09-01 | The study will examine the effects of estrogen and progesterone on the development of atherosclerosis in menopausal women when hormone treatment is initiated within 3 years of the menopausal transition. |
| NCT00154180 ↗ | Kronos Early Estrogen Prevention Study (KEEPS) | Unknown status | Mayo Clinic | Phase 4 | 2005-09-01 | The study will examine the effects of estrogen and progesterone on the development of atherosclerosis in menopausal women when hormone treatment is initiated within 3 years of the menopausal transition. |
| NCT00154180 ↗ | Kronos Early Estrogen Prevention Study (KEEPS) | Unknown status | University of California, San Francisco | Phase 4 | 2005-09-01 | The study will examine the effects of estrogen and progesterone on the development of atherosclerosis in menopausal women when hormone treatment is initiated within 3 years of the menopausal transition. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Climara Pro
Condition Name
Clinical Trial Locations for Climara Pro
Trials by Country
Clinical Trial Progress for Climara Pro
Clinical Trial Phase
Clinical Trial Sponsors for Climara Pro
Sponsor Name
